What changed from existing technology?
This study uses computer models to find natural substances that can reduce inflammation by targeting a specific protein involved in the body's inflammatory response.
This is the first study to apply machine learning models to predict the anti-inflammatory activity of natural products targeting NF-κB p65, a key protein in inflammatory signaling pathways.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Early research
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This approach could be used to discover new natural anti-inflammatory compounds for pharmaceutical development and nutraceutical applications.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.